ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 35 filers reported holding ESSA PHARMA INC in Q3 2023. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,080 | +162.8% | 12,000 | +129.7% | 0.00% | – |
| Q2 2023 | $14,107 | -9.1% | 5,225 | 0.0% | 0.00% | – |
| Q1 2023 | $15,518 | +19.4% | 5,225 | 0.0% | 0.00% | – |
| Q4 2022 | $13,000 | +62.5% | 5,225 | +23.7% | 0.00% | – |
| Q3 2022 | $8,000 | -38.5% | 4,225 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | -50.0% | 4,225 | 0.0% | 0.00% | – |
| Q1 2022 | $26,000 | -60.0% | 4,225 | -7.3% | 0.00% | – |
| Q4 2021 | $65,000 | +27.5% | 4,559 | -28.8% | 0.00% | – |
| Q3 2021 | $51,000 | -92.3% | 6,401 | -72.4% | 0.00% | -100.0% |
| Q2 2021 | $662,000 | +3.8% | 23,165 | +5.6% | 0.00% | -50.0% |
| Q1 2021 | $638,000 | +282.0% | 21,945 | +56.8% | 0.00% | – |
| Q4 2020 | $167,000 | +153.0% | 14,000 | +47.4% | 0.00% | – |
| Q3 2020 | $66,000 | +11.9% | 9,500 | 0.0% | 0.00% | – |
| Q2 2020 | $59,000 | +73.5% | 9,500 | +11.8% | 0.00% | – |
| Q1 2020 | $34,000 | – | 8,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,826,980 | $12,606,000 | 6.68% |
| Omega Fund Management, LLC | 912,693 | $6,096,000 | 1.65% |
| BVF INC/IL | 3,005,589 | $20,739,000 | 1.13% |
| Sio Capital Management, LLC | 656,043 | $4,527,000 | 0.90% |
| Avidity Partners Management LP | 2,087,800 | $14,406,000 | 0.67% |
| Vivo Capital, LLC | 1,516,865 | $10,466,000 | 0.60% |
| Opaleye Management Inc. | 271,350 | $1,872,000 | 0.37% |
| Eventide Asset Management | 2,335,169 | $15,307,000 | 0.30% |
| CAXTON CORP | 26,590 | $183,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $1,725,000 | 0.17% |